Stanley Fahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stanley Fahn has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Aia Elise Jønch
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
2 shared publications Blair Ford
Columbia University Movement Disorders Surgery Center, Department of Neurology, Movement Disorders
2 shared publicationsC. Warren Olanow
Neurological Institute New York New York USA
2 shared publicationsDaphne Robakis
Department of Neurology College of Physicians and Surgeons Columbia University New York New York USA
2 shared publications- Deborah A. Hall
Department of Neurological Sciences Rush University Medical Center Chicago IL
2 shared publications - Elizabeth Berry-Kravis
Rush University Medical Center, Chicago, USA
2 shared publications
Latest Publications
- 22 September 2025
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 16 (6) , a041954
Parkinson's Disease, Second Edition
Parkinson's disease (PD), once stigmatized and hidden, is now widely acknowledged by patients and recognized by the public. Yet, fundamental questions about the disease's origins, mechanisms, and progression remain unanswered. The second edition of Parkinson's Disease provides an integrated, accessible resource for clinicians and research scientists. It offers a comprehensive bench-to-bedside overview of PD, with contributions from leading experts in the clinical spectrum and the pathology, genetics, and neurobiological aspects of the condition. New chapters reflect recent advances in areas such as disease progression, biomarkers, cell-based therapies, lipid biology, and the gut–brain axis. The book emphasizes the need for interdisciplinary collaboration and serves as an educational entry point to the field and a strategic guide to future PD research.
- 22 September 2025
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 16 (6) , a041954
Parkinson's Disease, Second Edition
Parkinson's disease (PD), once stigmatized and hidden, is now widely acknowledged by patients and recognized by the public. Yet, fundamental questions about the disease's origins, mechanisms, and progression remain unanswered. The second edition of Parkinson's Disease provides an integrated, accessible resource for clinicians and research scientists. It offers a comprehensive bench-to-bedside overview of PD, with contributions from leading experts in the clinical spectrum and the pathology, genetics, and neurobiological aspects of the condition. New chapters reflect recent advances in areas such as disease progression, biomarkers, cell-based therapies, lipid biology, and the gut–brain axis. The book emphasizes the need for interdisciplinary collaboration and serves as an educational entry point to the field and a strategic guide to future PD research.
- 27 August 2021
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (7) , 993-996
What Is the Most Important and Impactful Paper Related to Movement Disorder Therapy Published in the 20th Century?
- 27 August 2021
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (7) , 993-996
What Is the Most Important and Impactful Paper Related to Movement Disorder Therapy Published in the 20th Century?
- 19 November 2020
- Published by Springer Nature
- Vol. 89, 7-35
The Early History of Paroxysmal Dyskinesias
- 19 November 2020
- Published by Springer Nature
- Vol. 89, 7-35
The Early History of Paroxysmal Dyskinesias
- 21 June 2019
- Published by Springer Nature
- p. 47-49
FAHN, Stanley: New York/USA
- 23 May 2019
- Published by Springer Nature
- p. 229-231
Treatment of Status Dystonicus (Dystonic Storm)
- 9 May 2019
- Published by Springer Nature
- p. 459-536
Movement Disorders
- 17 January 2019
- Published by Wiley in Movement Disorders
- Vol. 34 (1) , 35-40
In memoriam: Robert E. Burke, MD, 1949–2018
- 17 January 2019
- Published by Wiley in Movement Disorders
- Vol. 34 (1) , 35-40
In memoriam: Robert E. Burke, MD, 1949–2018
- 1 January 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 46, S1-S5
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
- 1 January 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 46, S1-S5
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
- 15 April 2016
- Published by Wiley in Movement Disorders
- Vol. 31 (4) , 493-496
Oliver Sacks, MD, 1933-2015
- 15 April 2016
- Published by Wiley in Movement Disorders
- Vol. 31 (4) , 493-496
Oliver Sacks, MD, 1933-2015
- 3 August 2015
- Published by Wiley in Movement Disorders
- Vol. 30 (14) , 1874-1884
Clinicopathological characteristics of freezing of gait in autopsy‐confirmed Parkinson's disease
Background: Twenty‐five percent to sixty percent of Parkinson's disease (PD) patients reportedly have freezing of gait, leading to impaired mobility, falls, and decreased quality of life. Several factors have been associated with gait freezing in PD patients. We analyze for these factors in autopsy‐proven PD patients.Methods: We performed a chart review of 58 patients with pathologically confirmed PD based on substantia nigra Lewy bodies. Freezing of gait was defined as a score of 1 or more on Item 14 of the Unified Parkinson's Disease Rating Scale or if documented on examination. Serial office notes and scales were used to determine onset and progression of motor and non‐motor symptoms.Results: Patients had been followed up for an average of 20 visits over 9 y. The mean onset of gait freezing was 9.3 y from initial motor symptoms. Patients with earlier gait freezing more commonly had initial gait difficulties and developed postural instability, dyskinesias, memory impairment, hallucinations, and vivid dreams earlier during the disease course. Early onset of hallucinations was correlated with more rapid progression of gait freezing. Maximal equivalent levodopa dose was not correlated with earlier onset or progression of gait freezing. Progressive and more severe gait freezing trended toward higher‐severity Lewy body disease on postmortem examination.Conclusions: Early onset and rapid progression of freezing of gait in this cohort were correlated with early cognitive impairment and hallucinations that are potential clinical hallmarks of cortical Lewy bodies. The gradual worsening and severity of gait freezing correlated with the density of cortical Lewy body–containing neurons. © 2015 International Parkinson and Movement Disorder Society
- 3 August 2015
- Published by Wiley in Movement Disorders
- Vol. 30 (14) , 1874-1884
Clinicopathological characteristics of freezing of gait in autopsy‐confirmed Parkinson's disease
Background: Twenty‐five percent to sixty percent of Parkinson's disease (PD) patients reportedly have freezing of gait, leading to impaired mobility, falls, and decreased quality of life. Several factors have been associated with gait freezing in PD patients. We analyze for these factors in autopsy‐proven PD patients.Methods: We performed a chart review of 58 patients with pathologically confirmed PD based on substantia nigra Lewy bodies. Freezing of gait was defined as a score of 1 or more on Item 14 of the Unified Parkinson's Disease Rating Scale or if documented on examination. Serial office notes and scales were used to determine onset and progression of motor and non‐motor symptoms.Results: Patients had been followed up for an average of 20 visits over 9 y. The mean onset of gait freezing was 9.3 y from initial motor symptoms. Patients with earlier gait freezing more commonly had initial gait difficulties and developed postural instability, dyskinesias, memory impairment, hallucinations, and vivid dreams earlier during the disease course. Early onset of hallucinations was correlated with more rapid progression of gait freezing. Maximal equivalent levodopa dose was not correlated with earlier onset or progression of gait freezing. Progressive and more severe gait freezing trended toward higher‐severity Lewy body disease on postmortem examination.Conclusions: Early onset and rapid progression of freezing of gait in this cohort were correlated with early cognitive impairment and hallucinations that are potential clinical hallmarks of cortical Lewy bodies. The gradual worsening and severity of gait freezing correlated with the density of cortical Lewy body–containing neurons. © 2015 International Parkinson and Movement Disorder Society